glucose, (beta-d)-isomer has been researched along with Donohue Syndrome in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dib, SA; Dos Santos, SS; Gabbay, MAL; Moises, RCS; Ramaldes, LA | 1 |
1 other study(ies) available for glucose, (beta-d)-isomer and Donohue Syndrome
| Article | Year |
|---|---|
Use of a Sodium-Glucose Cotransporter 2 Inhibitor, Empagliflozin, in a Patient with Rabson-Mendenhall Syndrome.
Topics: Antigens, CD; Benzhydryl Compounds; Child; Donohue Syndrome; Glucosides; Humans; Insulin Resistance; Male; Mutation; Receptor, Insulin; Sodium-Glucose Transporter 2 Inhibitors | 2021 |